WCM Investment Management CA raised its position in Natus Medical Inc (NASDAQ:BABY) by 23.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 215,894 shares of the medical equipment provider’s stock after purchasing an additional 40,344 shares during the period. WCM Investment Management CA owned 0.65% of Natus Medical worth $7,697,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Sei Investments Co. increased its position in shares of Natus Medical by 46.3% in the 2nd quarter. Sei Investments Co. now owns 4,669 shares of the medical equipment provider’s stock valued at $161,000 after purchasing an additional 1,478 shares during the last quarter. Tower Research Capital LLC TRC increased its position in shares of Natus Medical by 1,010.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,132 shares of the medical equipment provider’s stock valued at $177,000 after purchasing an additional 4,670 shares during the last quarter. Xact Kapitalforvaltning AB purchased a new stake in shares of Natus Medical in the 2nd quarter valued at approximately $201,000. Penn Davis Mcfarland Inc. purchased a new stake in shares of Natus Medical in the 2nd quarter valued at approximately $224,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of Natus Medical in the 2nd quarter valued at approximately $244,000. 96.07% of the stock is currently owned by institutional investors.
Shares of NASDAQ BABY traded up $0.26 during mid-day trading on Friday, reaching $31.52. The company had a trading volume of 501 shares, compared to its average volume of 297,256. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.21 and a quick ratio of 2.31. The company has a market capitalization of $1.01 billion, a price-to-earnings ratio of 21.72 and a beta of 0.59. Natus Medical Inc has a 52-week low of $27.69 and a 52-week high of $43.60.
Natus Medical (NASDAQ:BABY) last posted its earnings results on Wednesday, October 24th. The medical equipment provider reported $0.40 EPS for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.02). The company had revenue of $130.60 million during the quarter, compared to analysts’ expectations of $132.92 million. Natus Medical had a negative net margin of 3.53% and a positive return on equity of 11.34%. The company’s quarterly revenue was up 6.5% on a year-over-year basis. During the same period last year, the business earned $0.40 earnings per share. As a group, sell-side analysts forecast that Natus Medical Inc will post 1.48 earnings per share for the current year.
BABY has been the topic of a number of recent analyst reports. BidaskClub raised shares of Natus Medical from a “hold” rating to a “buy” rating in a research report on Thursday, August 2nd. Zacks Investment Research raised shares of Natus Medical from a “sell” rating to a “hold” rating in a research report on Friday, August 10th. ValuEngine raised shares of Natus Medical from a “sell” rating to a “hold” rating in a research report on Saturday, July 28th. Finally, Roth Capital set a $36.00 target price on shares of Natus Medical and gave the company a “buy” rating in a research report on Thursday, October 25th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $42.50.
In related news, insider Jonathan Kennedy sold 47,600 shares of the stock in a transaction on Thursday, August 30th. The shares were sold at an average price of $36.85, for a total value of $1,754,060.00. Following the transaction, the insider now directly owns 161,628 shares of the company’s stock, valued at approximately $5,955,991.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 5.50% of the company’s stock.
About Natus Medical
Natus Medical Incorporated provides newborn care, neurology, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.
Featured Article: Put Option
Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Inc (NASDAQ:BABY).
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.